📄Overview
CH-GRC-STORES/SOUTH EASTERN RLY has invited open tender bids for "Running Contract for Inj.Insulin Aspart Rapid acting analogue 100 IU/ml, 3 ml Cartridge, with provision of atleast one f......" at India — a Defence / Paramilitary goods on a Goods basis, carrying an estimated value of about ₹40.41 L (derived from the EMD, as the department didn't publish it). Bids close on 11 June 2026. EMD is ₹81 K. Reference HB266056.
🗓️Timeline
Published
—
Submission opens
—
Submission closes
11 Jun 2026
Bid opening
—
📎Tender documents
Documents are mirrored from the source portal for reference. Live bidding and authoritative documents remain on the official portal.
📋Complete tender details
🏷️ Identification
Tender IDIREPS-HB266056
Reference No.HB266056
OrganisationCH-GRC-STORES/SOUTH EASTERN RLY
Product categoryGoods & Services
💰 Commercials
Estimated value₹40.41 L
Form of contractGoods
EMD₹80,810
Tender feeNil
⚖️ Process & eligibility
Tender typeOpen Tender
CategoryGoods
Two-stage bidding—
Withdrawal allowed—
📍 Location & authority
LocationIndia
Inviting authorityCH-GRC-STORES/SOUTH EASTERN RLY
❓Frequently asked questions
What is this tender for?
CH-GRC-STORES/SOUTH EASTERN RLY floated this tender for "Running Contract for Inj.Insulin Aspart Rapid acting analogue 100 IU/ml, 3 ml Cartridge, with provision of atleast one f......" — Defence / Paramilitary work, procured as a goods contract on a Goods basis.
What is the estimated value?
The value was not disclosed; based on the EMD it works out to about ₹40.41 L.
What are the EMD and tender fee?
EMD is ₹81 K; tender fee is nil.
When do bids close?
Bids close on 11 June 2026.